PARP inhibitors in melanoma treatment: Potential, challenges, and future directions

Authors

• Angela Anaeme, Washington University School of Medicine in St. Louis
• Karen Moussa, University of Missouri
• Abdallah N Mansour, University of Athens
• George Nassief, Washington University School of Medicine in St. Louis
• George Ansstas, Washington University School of Medicine in St. Louis

Journal

Frontiers in Oncology

Publication Date

1-1-2025

Volume

15

First Page

1552386

Document Type

Open Access Publication

DOI

10.3389/fonc.2025.1552386

Rights and Permissions

Anaeme A, Moussa K, Mansour AN, Nassief G and Ansstas G (2025) PARP inhibitors in melanoma treatment: potential, challenges, and future directions. Front. Oncol. 15:1552386. doi: 10.3389/fonc.2025.1552386 © 2025 Anaeme, Moussa, Mansour, Nassief and Ansstas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Anaeme, Angela; Moussa, Karen; Mansour, Abdallah N; Nassief, George; and Ansstas, George, "PARP inhibitors in melanoma treatment: Potential, challenges, and future directions." Frontiers in Oncology. 15, 1552386 (2025).
https://digitalcommons.wustl.edu/oa_4/7552